Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS‐CoV‐2 vaccination in kidney transplant recipients

Kidney transplant recipients (KTRs) are extremely vulnerable to SARS‐CoV‐2 infection and show an impaired immune response to SARS‐CoV‐2 vaccination. We analyzed factors related to vaccination efficiency in KTRs. In a multicenter prospective observational study (NCT04743947), IgG antibodies levels ag...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2022-02, Vol.22 (2), p.634-639
Hauptverfasser:	Kantauskaite, Marta, Müller, Lisa, Kolb, Thilo, Fischer, Svenja, Hillebrandt, Jonas, Ivens, Katrin, Andree, Marcel, Luedde, Tom, Orth, Hans M., Adams, Ortwin, Schaal, Heiner, Schmidt, Claudia, Königshausen, Eva, Rump, Lars C., Timm, Jörg, Stegbauer, Johannes
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Viral Brief Communication Brief Communications clinical research/practice COVID-19 COVID-19 Vaccines Humans Immune response Immunity Immunoglobulin G immunosuppression/immune modulation Immunosuppressive agents immunosuppressive regimens infection and infectious agents ‐ viral Kidney transplantation Kidney Transplantation - adverse effects kidney transplantation/nephrology Kidney transplants Mycophenolate mofetil Mycophenolic acid Mycophenolic Acid - therapeutic use SARS-CoV-2 Seroconversion Severe acute respiratory syndrome coronavirus 2 Transplant Recipients Vaccination vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!